Get the Stockscreener App
8.75
0.23%
-0.02
Pre-market:
8.69
-0.06
-0.69%
Direxion Daily S P Biotech Bear 3 X Etf Stock (LABD) Forecast
The Direxion Daily S P Biotech Bear 3 X Etf (LABD) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $240.40, representing a +2,647% increase from the current price of $8.75. The highest analyst price target is $240.56, and the lowest is $240.23.
Note: Our forecast model does not currently account for dividend and stock split events. This means that our forecast may not be accurate for stocks that have recently experienced either of these events.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month LABD Price Target
Average 198.54
(+2,169% Upside)
Is Direxion Daily S P Biotech Bear 3 X Etf (LABD) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 47.05 | Neutral |
| STOCH(9,6) | 70.46 | Neutral |
| STOCHRSI(14) | 99.23 | Sell |
| MACD(12,26) | -0.577 | Buy |
| ADX(14) | 22.88 | Neutral |
| William %R | -13.03 | Sell |
| CCI(14) | 45.02 | Neutral |
Buy: 1
Sell: 2
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
8.403
Buy
|
8.4256
Buy
|
| MA20 |
7.924
Buy
|
8.6595
Buy
|
| MA50 |
11.02
Sell
|
10.47
Sell
|
| MA100 |
13.61
Sell
|
13.71
Sell
|
| MA200 |
18.41
Sell
|
24.59
Sell
|
Buy: 4
Sell: 6
Neutral: 0
Summary: Sell
According to our latest analysis, LABD could be considered a Moderate Sell, with 17 technical analysis indicators signaling 5 Buy signals, 8 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on LABD, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 47.05 indicates that LABD is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 70.46 indicates that LABD is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 99.23 indicates that LABD is oversold. This suggests that LABD price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 22.88 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 45.02 indicates that LABD is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term LABD price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Direxion Daily S P Biotech Bear 3 X Etf financial reports and earnings history, Direxion Daily S P Biotech Bear 3 X Etf (LABD) stock could reach $378.52 by 2030, $288.22 by 2040 and $954.75 by 2050. See the projected annual prices until 2050 of the Direxion Daily S P Biotech Bear 3 X Etf stock below:
- Direxion Daily S P Biotech Bear 3 X Etf (LABD) is expected to reach an average price of $80.83 in 2035, with a high prediction of $80.94 and a low estimate of $81.52. This indicates an $823.74% rise from the last recorded price of $8.75.
- Direxion Daily S P Biotech Bear 3 X Etf (LABD) stock is projected to chart a bullish course in 2040, with an average price target of $280.12, representing an $3,101% surge from its current level. The forecast ranges from a conservative $281.22 to a sky-high $288.22.
- Our analysts predict Direxion Daily S P Biotech Bear 3 X Etf (LABD) to jump 6,348% by 2045, soaring from $567.56 to an average price of $564.18, potentially reaching $583.17. While $567.56 is the low estimate, the potential upside is significant.
- Direxion Daily S P Biotech Bear 3 X Etf (LABD) stock is expected to climb by 2050, reaching an average of $940.80, a $10,652% jump from its current level. However, a wide range of estimates exists, with high and low targets of $954.75 and $941.40, respectively, highlighting the market's uncertainty.
Direxion Daily S P Biotech Bear 3 X Etf Stock (LABD) Year by Year Forecast
Direxion Daily S P Biotech Bear 3 X Etf Stock (LABD) Price Forecast for 2026
The predicted value for Direxion Daily S P Biotech Bear 3 X Etf (LABD) in 2026 is set at an average of $246.34. Estimates vary from a peak of $275.23 to a trough of $217.45, indicating an +2,715% surge from the present price of $8.75.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| August, 2026 | $242.47 | $240.23 | $240.56 | +2,671% |
| September, 2026 | $234.71 | $236.07 | $238.69 | +2,582% |
| October, 2026 | $226.72 | $227.79 | $228.26 | +2,491% |
| November, 2026 | $224.25 | $222.41 | $223.64 | +2,463% |
| December, 2026 | $214.38 | $217.45 | $222.80 | +2,350% |
Direxion Daily S P Biotech Bear 3 X Etf Stock (LABD) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Direxion Daily S P Biotech Bear 3 X Etf (LABD) is $167.28, with a high forecast of $211.29 and a low forecast of $123.27. This indicates an +1,812% increase from the last price of $8.75.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $208.06 | $208.50 | $211.29 | +2,278% |
| February, 2027 | $201.78 | $204.24 | $205.76 | +2,206% |
| March, 2027 | $193.19 | $193.84 | $196.42 | +2,108% |
| April, 2027 | $177.13 | $180.97 | $189.65 | +1,924% |
| May, 2027 | $162.97 | $167.82 | $163.51 | +1,762% |
| June, 2027 | $149.31 | $159.90 | $161.80 | +1,606% |
| July, 2027 | $156.99 | $156.52 | $155.21 | +1,694% |
| August, 2027 | $139.67 | $149.79 | $155.87 | +1,496% |
| September, 2027 | $127.18 | $124.13 | $124.86 | +1,354% |
| October, 2027 | $119.51 | $123.27 | $118.53 | +1,266% |
| November, 2027 | $141.81 | $133.80 | $130.22 | +1,521% |
| December, 2027 | $143.70 | $138.39 | $140.76 | +1,542% |
Direxion Daily S P Biotech Bear 3 X Etf Stock (LABD) Price Forecast for 2028
In 2028, Direxion Daily S P Biotech Bear 3 X Etf (LABD) is projected to reach an average price of $104.52, with a high projection of $138.16 and a low estimate of $70.88. This indicates an +1,095% rise from the last price of $8.75.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $132.07 | $134.19 | $138.16 | +1,409% |
| February, 2028 | $124.51 | $127.05 | $129.10 | +1,323% |
| March, 2028 | $121.02 | $122.17 | $122.50 | +1,283% |
| April, 2028 | $115.47 | $116.28 | $116.37 | +1,220% |
| May, 2028 | $109.19 | $110.84 | $113.51 | +1,148% |
| June, 2028 | $107.30 | $108.56 | $106.69 | +1,126% |
| July, 2028 | $101.08 | $103.53 | $105.47 | +1,055% |
| August, 2028 | $87.56 | $93.14 | $98.91 | +900.73% |
| September, 2028 | $83.07 | $83.87 | $85.62 | +849.34% |
| October, 2028 | $83.89 | $83.21 | $82.26 | +858.75% |
| November, 2028 | $77.28 | $77.28 | $81.76 | +783.20% |
| December, 2028 | $70.09 | $70.88 | $75.49 | +701.07% |
Direxion Daily S P Biotech Bear 3 X Etf Stock (LABD) Price Forecast for 2029
The 2029 price forecast for Direxion Daily S P Biotech Bear 3 X Etf Stock (LABD) is $203.28 on average, with a high prediction of $404.54 and a low estimate of $2.0211. This represents an +2,223% increase from the previous price of $8.75.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $63.44 | $63.52 | $67.36 | +625.06% |
| February, 2029 | $54.62 | $55.36 | $60.29 | +524.18% |
| March, 2029 | $47.74 | $49.81 | $52.91 | +445.59% |
| April, 2029 | $36.34 | $39.20 | $43.26 | +315.34% |
| May, 2029 | $27.43 | $28.81 | $31.59 | +213.51% |
| June, 2029 | $31.22 | $31.24 | $30.03 | +256.74% |
| July, 2029 | $31.15 | $31.61 | $30.75 | +255.98% |
| August, 2029 | $23.54 | $24.58 | $28.96 | +169.00% |
| September, 2029 | $20.00 | $20.20 | $21.82 | +128.58% |
| October, 2029 | $12.87 | $13.78 | $18.49 | +47.09% |
| November, 2029 | $3.8636 | $5.7936 | $11.13 | -55.84% |
| December, 2029 | $427.34 | $2.0211 | $404.54 | +4,784% |
Direxion Daily S P Biotech Bear 3 X Etf Stock (LABD) Price Forecast for 2030
Direxion Daily S P Biotech Bear 3 X Etf Stock (LABD) is expected to reach an average price of $422.20 in 2030, with a high forecast of $526.24 and a low forecast of $318.16. This signifies an +4,725% surge from the last price of $8.75.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $398.80 | $421.91 | $378.52 | +4,458% |
| February, 2030 | $464.97 | $490.58 | $480.07 | +5,214% |
| March, 2030 | $431.13 | $474.75 | $445.46 | +4,827% |
| April, 2030 | $374.50 | $394.70 | $382.42 | +4,180% |
| May, 2030 | $303.56 | $318.16 | $400.57 | +3,369% |
| June, 2030 | $384.92 | $329.14 | $343.64 | +4,299% |
| July, 2030 | $462.18 | $403.42 | $414.78 | +5,182% |
| August, 2030 | $533.35 | $519.04 | $521.55 | +5,995% |
| September, 2030 | $511.32 | $521.42 | $526.24 | +5,744% |
| October, 2030 | $519.37 | $483.59 | $511.57 | +5,836% |
| November, 2030 | $285.14 | $442.24 | $508.67 | +3,159% |
| December, 2030 | $412.51 | $381.83 | $416.76 | +4,614% |
0.12%
0.30%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):